Lotus Eye Hospital & Institute Reports Stable Financial Performance in Q2 FY25

Nov 18 2024 12:52 PM IST
share
Share Via
Despite a 'Sell' call from MarketsMojo, the company's score has improved from -1 to 2 in the last three months, indicating a positive outlook for the future. Lotus Eye Hospital & Institute, a microcap company in the hospital and healthcare services industry, has announced its financial results for the quarter ending September 2024. Despite a 'Sell' call from MarketsMojo, the company has shown a flat financial performance with a significant improvement in its score and strong operating cash flow.

Lotus Eye Hospital & Institute, a microcap company in the hospital and healthcare services industry, recently announced its financial results for the quarter ending September 2024. The results, declared on November 13, 2024, have received a ‘Sell’ call from MarketsMOJO.

Despite the negative recommendation, Lotus Eye Hospital has shown a flat financial performance in the second quarter of the fiscal year 2024-2025. However, there has been a significant improvement in the company’s score, which has increased from -1 to 2 in the last three months.


One of the key factors contributing to this improvement is the company’s strong operating cash flow. In the last three years, Lotus Eye Hospital has recorded the highest annual operating cash flow of Rs 5.68 crore. This indicates that the company has been able to generate higher cash revenues from its business operations.


Moreover, the company’s net sales for the quarter have also been the highest in the last five quarters, standing at Rs 12.91 crore. This shows a positive trend in the near-term sales performance of Lotus Eye Hospital.


Overall, the financial results for the quarter ending September 2024 reflect a stable performance by Lotus Eye Hospital & Institute. With its strong operating cash flow and positive sales trend, the company is well-positioned to continue its growth in the hospital and healthcare services industry.


{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News